advertisement

Oculus

14 Costing studies; pharmacoeconomics (827)

Showing records 1 to 25

Display only abstracts from IGR 22-1 in classification 14 Costing studies; pharmacoeconomics

Search within classification 14 Costing studies; pharmacoeconomics

94503 Cost Analysis and Rational Use of Anti-Glaucoma Therapy in a Tertiary Hospital in Ghana
Ofei-Palm CNK
ClinicoEconomics and outcomes research : CEOR 2021; 13: 619-627 (IGR: 22-2)


95048 A cost-effectiveness analysis of iStent inject combined with phacoemulsification cataract surgery in patients with mild-to-moderate open-angle glaucoma in France
Nieland K
PLoS ONE 2021; 16: e0252130 (IGR: 22-2)


94810 Impact of discontinuing government-funded routine eye exams on new glaucoma diagnoses in Ontario
Jin YP
Canadian Journal of Ophthalmology 2021; 0: (IGR: 22-2)


94503 Cost Analysis and Rational Use of Anti-Glaucoma Therapy in a Tertiary Hospital in Ghana
Tagoe NN
ClinicoEconomics and outcomes research : CEOR 2021; 13: 619-627 (IGR: 22-2)


94810 Impact of discontinuing government-funded routine eye exams on new glaucoma diagnoses in Ontario
Buys YM
Canadian Journal of Ophthalmology 2021; 0: (IGR: 22-2)


95048 A cost-effectiveness analysis of iStent inject combined with phacoemulsification cataract surgery in patients with mild-to-moderate open-angle glaucoma in France
Labbé A; Schweitzer C
PLoS ONE 2021; 16: e0252130 (IGR: 22-2)


94503 Cost Analysis and Rational Use of Anti-Glaucoma Therapy in a Tertiary Hospital in Ghana
Jatoe D
ClinicoEconomics and outcomes research : CEOR 2021; 13: 619-627 (IGR: 22-2)


94810 Impact of discontinuing government-funded routine eye exams on new glaucoma diagnoses in Ontario
Vujicic M
Canadian Journal of Ophthalmology 2021; 0: (IGR: 22-2)


94503 Cost Analysis and Rational Use of Anti-Glaucoma Therapy in a Tertiary Hospital in Ghana
Agyare A
ClinicoEconomics and outcomes research : CEOR 2021; 13: 619-627 (IGR: 22-2)


94810 Impact of discontinuing government-funded routine eye exams on new glaucoma diagnoses in Ontario
El-Defrawy S; El-Defrawy S
Canadian Journal of Ophthalmology 2021; 0: (IGR: 22-2)


95048 A cost-effectiveness analysis of iStent inject combined with phacoemulsification cataract surgery in patients with mild-to-moderate open-angle glaucoma in France
Gicquel G
PLoS ONE 2021; 16: e0252130 (IGR: 22-2)


94810 Impact of discontinuing government-funded routine eye exams on new glaucoma diagnoses in Ontario
Brent MH
Canadian Journal of Ophthalmology 2021; 0: (IGR: 22-2)


95048 A cost-effectiveness analysis of iStent inject combined with phacoemulsification cataract surgery in patients with mild-to-moderate open-angle glaucoma in France
Kleintjens J
PLoS ONE 2021; 16: e0252130 (IGR: 22-2)


94503 Cost Analysis and Rational Use of Anti-Glaucoma Therapy in a Tertiary Hospital in Ghana
Ankrah D
ClinicoEconomics and outcomes research : CEOR 2021; 13: 619-627 (IGR: 22-2)


94810 Impact of discontinuing government-funded routine eye exams on new glaucoma diagnoses in Ontario
Jeon W
Canadian Journal of Ophthalmology 2021; 0: (IGR: 22-2)


95048 A cost-effectiveness analysis of iStent inject combined with phacoemulsification cataract surgery in patients with mild-to-moderate open-angle glaucoma in France
Ostawal A; Treur M
PLoS ONE 2021; 16: e0252130 (IGR: 22-2)


94810 Impact of discontinuing government-funded routine eye exams on new glaucoma diagnoses in Ontario
Trope GE
Canadian Journal of Ophthalmology 2021; 0: (IGR: 22-2)


95048 A cost-effectiveness analysis of iStent inject combined with phacoemulsification cataract surgery in patients with mild-to-moderate open-angle glaucoma in France
Falvey H
PLoS ONE 2021; 16: e0252130 (IGR: 22-2)


92000 Impact of iStent Micro-Bypass Shunt on Medicare Part B Glaucoma Surgical Expenditure
Lee JH
Ophthalmology. Glaucoma 2021; 4: 131-138 (IGR: 22-1)


92484 Clinical and Economic Burden of Glaucoma by Disease Severity: A United States Claims-Based Analysis
Shih V
Ophthalmology. Glaucoma 2021; 0: (IGR: 22-1)


92059 Medical Costs of and Changes in Glaucoma Treatment among Patients Newly Starting Glaucoma Care
Fukuda Y
Current Eye Research 2021; 0: 1-8 (IGR: 22-1)


92484 Clinical and Economic Burden of Glaucoma by Disease Severity: A United States Claims-Based Analysis
Shih V
Ophthalmology. Glaucoma 2021; 0: (IGR: 22-1)


92601 Evaluating multidisciplinary glaucoma care: visual field progression and loss of sight year analysis in the community vs hospital setting
Mushtaq Y
Eye 2021; 0: (IGR: 22-1)


92777 The Effect of Market Competition on the Price of Topical Eye Drops
Watane A
Seminars in Ophthalmology 2021; 0: 1-7 (IGR: 22-1)


92445 Comparing Healthcare Resource Utilization and Costs for Patients with Normal Tension Glaucoma Across Levels of Severity: A Retrospective Cohort Study
Beal B
Clinical Ophthalmology 2021; 15: 453-460 (IGR: 22-1)



Issue 22-1

Change Issue


advertisement

Oculus